Company Name:Aptinyx Inc.
CEO: Norbert G. Riedel

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders.


Key numbers

Market Capitalization:194678904
Shares Outstanding: 43846600
Float: 21932332
Next Earning Date:2020-03-19
TTm EPS: -1.7256
TTm Dividend Rate:
200 days moving average:3.54
50 days moving average: 3.73
One day percent Change: -3.48



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,